Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 269

1.

Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study.

Vitale A, Burra P, Frigo AC, Trevisani F, Farinati F, Spolverato G, Volk M, Giannini EG, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Cabibbo G, Felder M, Gasbarrini A, Sacco R, Foschi FG, Missale G, Morisco F, Svegliati Baroni G, Virdone R, Cillo U; Italian Liver Cancer (ITA.LI.CA) group.

J Hepatol. 2015 Mar;62(3):617-24. doi: 10.1016/j.jhep.2014.10.037. Epub 2014 Oct 30.

PMID:
25450706
2.

Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study.

Vitale A, Morales RR, Zanus G, Farinati F, Burra P, Angeli P, Frigo AC, Del Poggio P, Rapaccini G, Di Nolfo MA, Benvegnù L, Zoli M, Borzio F, Giannini EG, Caturelli E, Chiaramonte M, Trevisani F, Cillo U; Italian Liver Cancer group.

Lancet Oncol. 2011 Jul;12(7):654-62. doi: 10.1016/S1470-2045(11)70144-9. Epub 2011 Jun 16.

PMID:
21684210
3.

BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group.

Farinati F, Vanin V, Giacomin A, Pozzan C, Cillo U, Vitale A, Di Nolfo AM, Del Poggio P, Benvegnu' L, Rapaccini G, Zoli M, Borzio F, Giannini EG, Caturelli E, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group.

Liver Int. 2015 Jan;35(1):223-31. doi: 10.1111/liv.12649. Epub 2014 Aug 27.

PMID:
25074434
4.

Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.

Yau T, Tang VY, Yao TJ, Fan ST, Lo CM, Poon RT.

Gastroenterology. 2014 Jun;146(7):1691-700.e3. doi: 10.1053/j.gastro.2014.02.032. Epub 2014 Feb 25.

PMID:
24583061
5.

Risk factors and surgical outcomes for spontaneous rupture of BCLC stages A and B hepatocellular carcinoma: a case-control study.

Li J, Huang L, Liu CF, Cao J, Yan JJ, Xu F, Wu MC, Yan YQ.

World J Gastroenterol. 2014 Jul 21;20(27):9121-7. doi: 10.3748/wjg.v20.i27.9121.

6.

External validation of a simplified BCLC staging system for early hepatocellular carcinoma.

Santambrogio R, Salceda J, Costa M, Kluger MD, Barabino M, Laurent A, Opocher E, Azoulay D, Cherqui D.

Eur J Surg Oncol. 2013 Aug;39(8):850-7. doi: 10.1016/j.ejso.2013.05.001. Epub 2013 May 29.

PMID:
23726257
7.

Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective.

Li JW, Goh BG, Chang PE, Tan CK.

World J Gastroenterol. 2017 Jun 14;23(22):4054-4063. doi: 10.3748/wjg.v23.i22.4054.

8.

Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.

Zhong JH, Ke Y, Gong WF, Xiang BD, Ma L, Ye XP, Peng T, Xie GS, Li LQ.

Ann Surg. 2014 Aug;260(2):329-40. doi: 10.1097/SLA.0000000000000236.

PMID:
24096763
9.

Selection criteria for hepatic resection in intermediate-stage (BCLC stage B) multiple hepatocellular carcinoma.

Wada H, Eguchi H, Noda T, Ogawa H, Yamada D, Tomimaru Y, Tomokuni A, Asaoka T, Kawamoto K, Gotoh K, Marubashi S, Umeshita K, Nagano H, Doki Y, Mori M.

Surgery. 2016 Nov;160(5):1227-1235. doi: 10.1016/j.surg.2016.05.023. Epub 2016 Jul 7.

PMID:
27395761
10.

Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization.

Ciria R, López-Cillero P, Gallardo AB, Cabrera J, Pleguezuelo M, Ayllón MD, Luque A, Zurera L, Espejo JJ, Rodríguez-Perálvarez M, Montero JL, de la Mata M, Briceño J.

Eur J Surg Oncol. 2015 Sep;41(9):1153-61. doi: 10.1016/j.ejso.2015.05.023. Epub 2015 Jun 12.

PMID:
26118317
11.

Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: extending the indication for resection?

Chang WT, Kao WY, Chau GY, Su CW, Lei HJ, Wu JC, Hsia CY, Lui WY, King KL, Lee SD.

Surgery. 2012 Nov;152(5):809-20. doi: 10.1016/j.surg.2012.03.024. Epub 2012 Jul 3.

PMID:
22766361
12.

Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.

Kim H, Ahn SW, Hong SK, Yoon KC, Kim HS, Choi YR, Lee HW, Yi NJ, Lee KW, Suh KS; Korean Liver Cancer Association.

Br J Surg. 2017 Jul;104(8):1045-1052. doi: 10.1002/bjs.10541. Epub 2017 May 8.

PMID:
28480964
13.

Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.

Gomaa AI, Al-Khatib A, Abdel-Razek W, Hashim MS, Waked I.

World J Gastroenterol. 2015 May 14;21(18):5654-62. doi: 10.3748/wjg.v21.i18.5654.

14.

Surgical resection improves long-term survival of patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages.

Guo H, Wu T, Lu Q, Li M, Guo JY, Shen Y, Wu Z, Nan KJ, Lv Y, Zhang XF.

Cancer Manag Res. 2018 Feb 21;10:361-369. doi: 10.2147/CMAR.S152707. eCollection 2018.

16.

Survival benefit of hepatic resection for hepatocellular carcinoma beyond the Barcelona Clinic Liver Cancer classification.

Furukawa K, Shiba H, Horiuchi T, Shirai Y, Haruki K, Fujiwara Y, Sakamoto T, Gocho T, Yanaga K.

J Hepatobiliary Pancreat Sci. 2017 Apr;24(4):199-205. doi: 10.1002/jhbp.436. Epub 2017 Mar 12.

PMID:
28160422
17.

Treatment of hepatocellular carcinoma in a tertiary Romanian center. Deviations from BCLC recommendations and influence on survival rate.

Radu P, Groza I, Iancu C, Al Hajjar N, Andreica V, Sparchez Z.

J Gastrointestin Liver Dis. 2013 Sep;22(3):291-7.

18.

Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment.

Jun CH, Yoon JH, Cho E, Shin SS, Cho SB, Kim HJ, Park CH, Kim HS, Choi SK, Rew JS.

Medicine (Baltimore). 2017 Apr;96(17):e6745. doi: 10.1097/MD.0000000000006745.

19.

Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis.

Torzilli G, Donadon M, Marconi M, Palmisano A, Del Fabbro D, Spinelli A, Botea F, Montorsi M.

Arch Surg. 2008 Nov;143(11):1082-90. doi: 10.1001/archsurg.143.11.1082.

PMID:
19015467
20.

The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma.

Gómez-Rodríguez R, Romero-Gutiérrez M, Artaza-Varasa T, González-Frutos C, Ciampi-Dopazo JJ, de-la-Cruz-Pérez G, Sánchez-Ruano JJ.

Rev Esp Enferm Dig. 2012 Jun;104(6):298-304. English, Spanish.

Supplemental Content

Support Center